The Application Notebook
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a crucial mechanism of action (MoA) of anti-tumour therapeutic antibodies and FcγIIIa receptor plays a key role in this process by interacting with the N-glycans of IgG Fc regions. Hence, affinity chromatography on Fc receptor ligands can deliver valuable information about expected ADCC activity and mAb glycoform distribution.
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a crucial mechanism of action (MoA) of anti-tumour therapeutic antibodies and FcγIIIa receptor plays a key role in this process by interacting with the N-glycans of IgG Fc regions. Hence, affinity chromatography on Fc receptor ligands can deliver valuable information about expected ADCC activity and mAb glycoform distribution.
A new HPLC column, TSKgel FcR-IIIA-NPR, is based on a recombinant FcγIIIa receptor ligand and allows fast assessment of biologic activity of monoclonal antibodies (mAbs). As Fc-glycans of antibodies are known to play an important role in Fc-mediated interactions, the separation pattern of mAbs on TSKgel FcR-IIIAâNPR can be correlated to FC-glycans as well (1). Terminal galactose residues increase affinity to FcγRIIIa while core fucose residues reduce it. This correlates with the known influence of galactose and fucose on antibody-dependent cell-mediated cytotoxicity (ADCC) activity. Accordingly, early eluting peaks of TSKgel FcR-IIIA-NPR represent glycoforms with low ADCC activity, while late eluting peaks represent glycoforms with high ADCC activity (Figure 1).
Separation of mAb Glycoforms
Figure 2 demonstrates the specificity of the recombinant FcγRIIIA ligand for N-glycans of the Fc domain of mAbs. Adalimumab analyzed with TSKgel FcR-IIIA-NPR shows a typical pattern of three peaks, corresponding with the molecule’s glycan heterogeneity. Treatment of adalimumab with PNGase F de-glycosylates the sample. De-glycosylated adalimumab does not bind to TSKgel FcRâIIIA-NPR; the N-glycan related peaks are absent.
HPLC Conditions
Column: TSKgel FcR-IIIA-NPR (4.6 mm × 7.5 cm L, 5-µm)
Mobile Phase:
A: 50 mmol/L sodium citrate, pH 6.5;
B: 50 mmol/L sodium citrate, pH 4.5
Flow Rate: 1 mL/min
Temp.: 25 °C
Detection: UV @ 280 nm
Sample: 50 µL of adalimumab or PNGase F treated adalimumab (1 µg/µL)
Conclusion
A rapid 30-min separation on TSKgel FcR-IIIA-NPR allows the analysis of large numbers of mAb samples to gain valuable first information on the distribution of glycoforms and expected ADCC activity. This fast and efficient method can be applied to purified samples and supernatant alike and can be used in many phases of development and production such as cell line screening in early R&D, biosimilar or originator comparison, upstream development and optimization, monitoring of glycoengineering, or lot-to-lot comparison in QC.
Reference
Tosoh Bioscience GmbH
Im Leuschnerpark 4 64347 Griesheim, Darmstadt, Germany
Tel: +49 6155 7043700 Fax: +49 6155 8357900
E-mail: info.tbg@tosoh.com
Website: www.tosohbioscience.de
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.